Abstract
Background
In tuberous sclerosis complex (TSC), a substantially increased risk of develo** epilepsy is present as a result of a disruption of a TSC gene expression in the brain and secondary abnormal cellular differentiation, migration, and proliferation. Dysregulated excitation probably has its roots in the disruption of GABAergic interneuron development. There is an age-dependent electroclinical expression of seizures, and epilepsy is often quite severe and unremitting.
Discussion
The majority of patients (>60%) who are candidates for surgery remain seizure-free after tuberectomy. During the recent years technical advances in the localization of the epileptogenic zone during the recent years have lead to a 63% of Engel class I status after surgery compared with a previous 52%. In medically refractory patients not suitable for surgery, vagus nerve stimulation has proved efficacy in significantly reducing seizure frequency in more than 50% of cases. New evidence suggests that mTOR inhibitors may be helpful in the management of intractable epilepsy for individuals with TSC.
Similar content being viewed by others
References
Curatolo P, Bombardieri R, Jozwiak S (2008) Tuberous sclerosis. Lancet 372:657–668
Napolioni V, Moavero R, Curatolo P (2008) Recent advances in neurobiology of Tuberous Sclerosis Complex. Brain Dev
Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M, Stocker H, Kozma SC, Hafen E, Bos JL, Thomas G (2003) Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 11:1457–1466
van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, van den Ouweland A, Reuser A, Sampson J, Halley D, van der Sluijs P (1998) Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 7:1053–1057
Curatolo P, Brinchi V (1993) Antenatal diagnosis of tuberous sclerosis. Lancet 341:176–177
Park SH, Pepkowitz SH, Kerfoot C, De Rosa MJ, Poukens V, Wienecke R, DeClue JE, Vinters HV (1997) Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study. Acta Neuropathol 94:180–186
Talos DM, Kwiatkowski DJ, Cordero K, Black PM, Jensen FE (2008) Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann Neurol 63:454–465
Wolf HK, Birkholz T, Wellmer J, Blumcke I, Pietsch T, Wiestler OD (1995) Neurochemical profile of glioneuronal lesions from patients with pharmacoresistant focal epilepsies. J Neuropathol Exp Neurol 54:689–697
Toering, ST, Boer K, de Groot M, Troost D, Heimans JJ, Spliet WG, van Rijen PC, Jansen FE, Gorter JA, Reijneveld JC, Aronica E (2009) Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers. Epilepsia
Crowder KM, Gunther JM, Jones TA, Hale BD, Zhang HZ, Peterson MR, Scheller RH, Chavkin C, Bajjalieh SM (1999) Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci U S A 96:15268–15273
Boer K, Troost D, Jansen F, Nellist M, van den Ouweland AM, Geurts JJ, Spliet WG, Crino P, Aronica E (2008) Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex. Neuropathology
Lee A, Maldonado M, Baybis M, Walsh CA, Scheithauer B, Yeung R, Parent J, Weiner HL, Crino PB (2003) Markers of cellular proliferation are expressed in cortical tubers. Ann Neurol 53:668–673
Maldonado M, Baybis M, Newman D, Kolson DL, Chen W, McKhann G 2nd, Gutmann DH, Crino PB (2003) Expression of ICAM-1, TNF-alpha, NF kappa B, and MAP kinase in tubers of the tuberous sclerosis complex. Neurobiol Dis 14:279–290
Kaufmann R, Kornreich L, Goldberg-Stern H (2009) Unusual clinical presentation of tuberless tuberous sclerosis complex. J Child Neurol 24:361–364
White R, Hua Y, Scheithauer B, Lynch DR, Henske EP, Crino PB (2001) Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers. Ann Neurol 49:67–78
Ben-Ari Y, Gaiarsa JL, Tyzio R, Khazipov R (2007) GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol Rev 87:1215–1284
Calcagnotto ME, Paredes MF, Tihan T, Barbaro NM, Baraban SC (2005) Dysfunction of synaptic inhibition in epilepsy associated with focal cortical dysplasia. J Neurosci 25:9649–9657
Valencia I, Legido A, Yelin K, Khurana D, Kothare SV, Katsetos CD (2006) Anomalous inhibitory circuits in cortical tubers of human tuberous sclerosis complex associated with refractory epilepsy: aberrant expression of parvalbumin and calbindin-D28k in dysplastic cortex. J Child Neurol 21:1058–1063
Wang Y, Greenwood JS, Calcagnotto ME, Kirsch HE, Barbaro NM, Baraban SC (2007) Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1. Ann Neurol 61:139–152
Jensen FE (2006) Developmental factors regulating susceptibility to perinatal brain injury and seizures. Curr Opin Pediatr 18:628–633
Catania MV, D'Antoni S, Bonaccorso CM, Aronica E, Bear MF, Nicoletti F (2007) Group I metabotropic glutamate receptors: a role in neurodevelopmental disorders? Mol Neurobiol 35:298–307
Meador KJ (2007) The basic science of memory as it applies to epilepsy. Epilepsia 48(Suppl 9):23–25
Leite JP, Neder L, Arisi GM, Carlotti CG Jr, Assirati JA, Moreira JE (2005) Plasticity, synaptic strength, and epilepsy: what can we learn from ultrastructural data? Epilepsia 46(Suppl 5):134–141
Wong M (2008) Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia 49:8–21
Esclapez M, Hirsch JC, Ben-Ari Y, Bernard C (1999) Newly formed excitatory pathways provide a substrate for hyperexcitability in experimental temporal lobe epilepsy. J Comp Neurol 408:449–460
D'Argenzio L, Koch G, Bombardieri R, Mori F, Moavero R, Centonze D, Curatolo P (2009) Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex. Epilepsy Res 87:102–105
Scheidenhelm DK, Gutmann DH (2004) Mouse models of tuberous sclerosis complex. J Child Neurol 19:726–733
Takahashi DK, Dinday MT, Barbaro NM, Baraban SC (2004) Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex. Epilepsia 45:1525–1530
Wenzel HJ, Patel LS, Robbins CA, Emmi A, Yeung RS, Schwartzkroin PA (2004) Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis. Acta Neuropathol 108:97–108
Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL (2005) Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci 8:1727–1734
Uhlmann EJ, Wong M, Baldwin RL, Bajenaru ML, Onda H, Kwiatkowski DJ, Yamada K, Gutmann DH (2002) Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann Neurol 52:285–296
Wong M, Ess KC, Uhlmann EJ, Jansen LA, Li W, Crino PB, Mennerick S, Yamada KA, Gutmann DH (2003) Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model. Ann Neurol 54:251–256
Sosunov AA, Wu X, Weiner HL, Mikell CB, Goodman RR, Crino PD, McKhann GM 2nd (2008) Tuberous sclerosis: a primary pathology of astrocytes? Epilepsia 49(Suppl 2):53–62
Thiele EA (2004) Managing epilepsy in tuberous sclerosis complex. J Child Neurol 19:680–686
Sugita K, Itoh K, Takeuchi Y, Cho H, Kakinuma H, Nakajima H, Takase M (1985) Tuberous sclerosis: report of two cases studied by computer-assisted cranial tomography within one week after birth. Brain Dev 7:438–443
Curatolo P (2003) Tuberous sclerosis complex from basic science to clinical phenotypes. Mac Keith Press, ed. I.C.N. Association, 2003, London
Seri S, Cerquiglini A, Pisani F, Michel CM, Pascual Marqui RD, Curatolo P (1998) Frontal lobe epilepsy associated with tuberous sclerosis: electroencephalographic-magnetic resonance image fusioning. J Child Neurol 13:33–38
Dulac O, Lemaitre A, Plouin P (1984) The Bourneville syndrome: clinical and EEG features of epilepsy in the first year of life. Boll Lega Ital Epil 45:39–42
Curatolo P, Seri S, Verdecchia M, Bombardieri R (2001) Infantile spasms in tuberous sclerosis complex. Brain Dev 23:502–507
Curatolo P, Cusmai R, Cortesi F, Chiron C, Jambaque I, Dulac O (1991) Neuropsychiatric aspects of tuberous sclerosis. Ann N Y Acad Sci 615:8–16
Cusmai R, Chiron C, Curatolo P, Dulac O, Tran-Dinh S (1990) Topographic comparative study of magnetic resonance imaging and electroencephalography in 34 children with tuberous sclerosis. Epilepsia 31:747–755
Chu-Shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA (2009) The natural history of epilepsy in tuberous sclerosis complex. Epilepsia
Jansen FE, van Huffelen AC, Bourez-Swart M, van Nieuwenhuizen O (2005) Consistent localization of interictal epileptiform activity on EEGs of patients with tuberous sclerosis complex. Epilepsia 46:415–419
Ben-Ari Y, Holmes GL (2006) Effects of seizures on developmental processes in the immature brain. Lancet Neurol 5:1055–1063
Tyzio R, Holmes GL, Ben-Ari Y, Khazipov R (2007) Timing of the developmental switch in GABA(A) mediated signaling from excitation to inhibition in CA3 rat hippocampus using gramicidin perforated patch and extracellular recordings. Epilepsia 48(Suppl 5):96–105
O'Callaghan FJ, Harris T, Joinson C, Bolton P, Noakes M, Presdee D, Renowden S, Shiell A, Martyn CN, Osborne JP (2004) The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex. Arch Dis Child 89:530–533
Holmes GL (2005) Effects of seizures on brain development: lessons from the laboratory. Pediatr Neurol 33:1–11
Cornejo BJ, Mesches MH, Coultrap S, Browning MD, Benke TA (2007) A single episode of neonatal seizures permanently alters glutamatergic synapses. Ann Neurol 61:411–426
Jansen FE, Braams O, Vincken KL, Algra A, Anbeek P, Jennekens-Schinkel A, Halley D, Zonnenberg BA, van den Ouweland A, van Huffelen AC, van Nieuwenhuizen O, Nellist M (2008) Overlap** neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations. Neurology 70:908–915
Yamamoto T, Pipo JR, Feng JH, Takeda H, Nanba E, Ninomiya H, Ohno K (2002) Novel TSC1 and TSC2 mutations in Japanese patients with tuberous sclerosis complex. Brain Dev 24:227–230
Jansen AC, Sancak O, D'Agostino MD, Badhwar A, Roberts P, Gobbi G, Wilkinson R, Melanson D, Tampieri D, Koenekoop R, Gans M, Maat-Kievit A, Goedbloed M, van den Ouweland AM, Nellist M, Pandolfo M, McQueen M, Sims K, Thiele EA, Dubeau F, Andermann F, Kwiatkowski DJ, Halley DJ, Andermann E (2006) Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation. Ann Neurol 60:528–539
Mayer K, Goedbloed M, van Zijl K, Nellist M, Rott HD (2004) Characterisation of a novel TSC2 missense mutation in the GAP related domain associated with minimal clinical manifestations of tuberous sclerosis. J Med Genet 41:e64
O'Connor SE, Kwiatkowski DJ, Roberts PS, Wollmann RL, Huttenlocher PR (2003) A family with seizures and minor features of tuberous sclerosis and a novel TSC2 mutation. Neurology 61:409–412
Chu-Shore CJ, Major P, Montenegro M, Thiele E (2009) Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex. Neurology 72:1165–1169
Way SW, McKenna J 3rd, Mietzsch U, Reith RM, Wu HC, Gambello MJ (2009) Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Hum Mol Genet 18:1252–1265
Au KS, Ward CH, Northrup H (2008) Tuberous sclerosis complex: disease modifiers and treatments. Curr Opin Pediatr 20:628–633
Camposano SE, Greenberg E, Kwiatkowski DJ, Thiele EA (2009) Distinct clinical characteristics of tuberous sclerosis complex patients with no mutation identified. Ann Hum Genet 73:141–146
Bombardieri R, Pinci M, Moavero R, Cerminara C, Curatolo P (2009) Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. Eur J Paediatr Neurol
Jambaque I, Chiron C, Dumas C, Mumford J, Dulac O (2000) Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Epilepsy Res 38:151–160
Chiron C, Dulac O, Luna D, Palacios L, Mondragon S, Beaumont D, Mumford JP (1990) Vigabatrin in infantile spasms. Lancet 335:363–364
Hancock E, Osborne JP (1999) Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review. J Child Neurol 14:71–74
Curatolo P, Bombardieri R, Verdecchia M, Seri S (2005) Intractable seizures in tuberous sclerosis complex: from molecular pathogenesis to the rationale for treatment. J Child Neurol 20:318–325
Curatolo P, Bombardieri R, Cerminara C (2006) Current management for epilepsy in tuberous sclerosis complex. Curr Opin Neurol 19:119–123
Lortie A, Plouin P, Chiron C, Delalande O, Dulac O (2002) Characteristics of epilepsy in focal cortical dysplasia in infancy. Epilepsy Res 51:133–145
Moeller JJ, Rahey SR, Sadler RM (2009) Lamotrigine-valproic acid combination therapy for medically refractory epilepsy. Epilepsia 50:475–479
Kaminski RM, Matagne A, Patsalos PN, Klitgaard H (2009) Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam. Epilepsia 50:387–397
Lazarowski A, Lubieniecki F, Camarero S, Pomata H, Bartuluchi M, Sevlever G, Taratuto AL (2004) Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy. Pediatr Neurol 30:102–106
Bye AM, Matheson JM, Tobias VH, Mackenzie RA (1989) Selective epilepsy surgery in tuberous sclerosis. Aust Paediatr J 25:243–245
Baumgartner JE, Wheless JW, Kulkarni S, Northrup H, Au KS, Smith A, Brookshire B (1997) On the surgical treatment of refractory epilepsy in tuberous sclerosis complex. Pediatr Neurosurg 27:311–318
Chandra PS, Salamon N, Huang J, Wu JY, Koh S, Vinters HV, Mathern GW (2006) FDG-PET/MRI coregistration and diffusion-tensor imaging distinguish epileptogenic tubers and cortex in patients with tuberous sclerosis complex: a preliminary report. Epilepsia 47:1543–1549
Jacobs J, Rohr A, Moeller F, Boor R, Kobayashi E, LeVan Meng P, Stephani U, Gotman J, Siniatchkin M (2008) Evaluation of epileptogenic networks in children with tuberous sclerosis complex using EEG-fMRI. Epilepsia 49:816–825
Jansen FE, Huiskamp G, van Huffelen AC, Bourez-Swart M, Boere E, Gebbink T, Vincken KL, van Nieuwenhuizen O (2006) Identification of the epileptogenic tuber in patients with tuberous sclerosis: a comparison of high-resolution EEG and MEG. Epilepsia 47:108–114
Wu JY, Sutherling WW, Koh S, Salamon N, Jonas R, Yudovin S, Sankar R, Shields WD, Mathern GW (2006) Magnetic source imaging localizes epileptogenic zone in children with tuberous sclerosis complex. Neurology 66:1270–1272
Sugiyama I, Imai K, Yamaguchi Y, Ochi A, Akizuki Y, Go C, Akiyama T, Snead OC 3rd, Rutka JT, Drake JM, Widjaja E, Chuang SH, Cheyne D, Otsubo H (2009) Localization of epileptic foci in children with intractable epilepsy secondary to multiple cortical tubers by using synthetic aperture magnetometry kurtosis. J Neurosurg Pediatr 4:515–522
Kagawa K, Chugani DC, Asano E, Juhasz C, Muzik O, Shah A, Shah J, Sood S, Kupsky WJ, Mangner TJ, Chakraborty PK, Chugani HT (2005) Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-l-tryptophan positron emission tomography (PET). J Child Neurol 20:429–438
Guerreiro MM, Andermann F, Andermann E, Palmini A, Hwang P, Hoffman HJ, Otsubo H, Bastos A, Dubeau F, Snipes GJ, Olivier A, Rasmussen T (1998) Surgical treatment of epilepsy in tuberous sclerosis: strategies and results in 18 patients. Neurology 51:1263–1269
Palmini A, Andermann F, Olivier A, Tampieri D, Robitaille Y (1991) Focal neuronal migration disorders and intractable partial epilepsy: results of surgical treatment. Ann Neurol 30:750–757
Major P, Rakowski S, Simon MV, Cheng ML, Eskandar E, Baron J, Leeman BA, Frosch MP, Thiele EA (2009) Are cortical tubers epileptogenic? Evidence from electrocorticography. Epilepsia 50:147–154
Jansen FE, van Huffelen AC, Algra A, van Nieuwenhuizen O (2007) Epilepsy surgery in tuberous sclerosis: a systematic review. Epilepsia 48:1477–1484
Bollo RJ, Kalhorn SP, Carlson C, Haegeli V, Devinsky O, Weiner HL (2008) Epilepsy surgery and tuberous sclerosis complex: special considerations. Neurosurg Focus 25:E13
Iida K, Otsubo H, Mohamed IS, Okuda C, Ochi A, Weiss SK, Chuang SH, Snead OC 3rd (2005) Characterizing magnetoencephalographic spike sources in children with tuberous sclerosis complex. Epilepsia 46:1510–1517
Weiner HL, Ferraris N, LaJoie J, Miles D, Devinsky O (2004) Epilepsy surgery for children with tuberous sclerosis complex. J Child Neurol 19:687–689
Peng T, Golub TR, Sabatini DM (2002) The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol Cell Biol 22:5575–5584
Coppola G, Klepper J, Ammendola E, Fiorillo M, Corte R della, Capano G, Pascotto A (2006) The effects of the ketogenic diet in refractory partial seizures with reference to tuberous sclerosis. Eur J Paediatr Neurol 10:148–151
Kossoff EH, Thiele EA, Pfeifer HH, McGrogan JR, Freeman JM (2005) Tuberous sclerosis complex and the ketogenic diet. Epilepsia 46:1684–1686
Chu-Shore CJ, Thiele EA (2009) Tumor growth in patients with tuberous sclerosis complex on the ketogenic diet. Brain Dev
Parain D, Penniello MJ, Berquen P, Delangre T, Billard C, Murphy JV (2001) Vagal nerve stimulation in tuberous sclerosis complex patients. Pediatr Neurol 25:213–216
Elliott RE, Carlson C, Kalhorn SP, Moshel YA, Weiner HL, Devinsky O, Doyle WK (2009) Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery. Epilepsy Behav 16:454–460
Major P, Thiele EA (2008) Vagus nerve stimulation for intractable epilepsy in tuberous sclerosis complex. Epilepsy Behav 13:357–360
Zamponi N, Rychlicki F, Corpaci L, Cesaroni E, Trignani R (2008) Vagus nerve stimulation (VNS) is effective in treating catastrophic 1 epilepsy in very young children. Neurosurg Rev 31:291–297
Vonck K, De Herdt V, Bosman T, Dedeurwaerdere S, Van Laere K, Boon P (2008) Thalamic and limbic involvement in the mechanism of action of vagus nerve stimulation, a SPECT study. Seizure 17:699–706
Marrosu F, Serra A, Maleci A, Puligheddu M, Biggio G, Piga M (2003) Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy. Epilepsy Res 55:59–70
Mikati MA, Ataya NF, El-Ferezli JC, Baghdadi TS, Turkmani AH, Comair YG, Kansagra S, Najjar MW (2009) Quality of life after vagal nerve stimulator insertion. Epileptic Disord 11:67–74
Meikle L, Pollizzi K, Egnor A, Kramvis I, Lane H, Sahin M, Kwiatkowski DJ (2008) Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci 28:5422–5432
Zeng LH, Xu L, Gutmann DH, Wong M (2008) Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 63:444–453
Ehninger D, Han S, Shilyansky C, Zhou Y, Li W, Kwiatkowski DJ, Ramesh V, Silva AJ (2008) Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis. Nat Med 14:843–848
Muncy J, Butler IJ, Koenig MK (2009) Rapamycin reduces seizure frequency in tuberous sclerosis complex. J Child Neurol 24:477
Talos DM, Black PM, Jensen FE (2003) Dysplastic neurons in cortical tubers express selective alterations in AMPA and NMDA receptor subunits. Epilepsia 46:36
Perot P, Weir B, Rasmussen T (1966) Tuberous sclerosis. Surgical therapy for seizures. Arch Neurol 15:498–506
Bebin EM, Kelly PJ, Gomez MR (1993) Surgical treatment for epilepsy in cerebral tuberous sclerosis. Epilepsia 34:651–657
Avellino AM, Berger MS, Rostomily RC, Shaw CM, Ojemann GA (1997) Surgical management and seizure outcome in patients with tuberous sclerosis. J Neurosurg 87:391–396
Sugimoto T, Otsubo H, Hwang PA, Hoffman HJ, Jay V, Snead OC 3rd (1999) Outcome of epilepsy surgery in the first three years of life. Epilepsia 40:560–565
Wennberg R, Quesney LF, Lozano A, Olivier A, Rasmussen T (1999) Role of electrocorticography at surgery for lesion-related frontal lobe epilepsy. Can J Neurol Sci 26:33–39
Asano E, Chugani DC, Muzik O, Shen C, Juhasz C, Janisse J, Ager J, Canady A, Shah JR, Shah AK, Watson C, Chugani HT (2000) Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology 54:1976–1984
Koh S, Jayakar P, Dunoyer C, Whiting SE, Resnick TJ, Alvarez LA, Morrison G, Ragheb J, Prats A, Dean P, Gilman J, Duchowny MS (2000) Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome. Epilepsia 41:1206–1213
Leiphart JW, Peacock WJ, Mathern GW (2001) Lobar and multilobar resections for medically intractable pediatric epilepsy. Pediatr Neurosurg 34:311–318
Ohta Y, Nariai T, Akimoto H, Shimohira M, Sugimoto J, Ohno K, Senda M, Hirakawa K (2001) Tuberous sclerosis: epileptogenicity and multimodal presurgical evaluations. Childs Nerv Syst 17:313–319
Bittar RG, Rosenfeld JV, Klug GL, Hopkins IJ, Harvey AS (2002) Resective surgery in infants and young children with intractable epilepsy. J Clin Neurosci 9:142–146
Karenfort M, Kruse B, Freitag H, Pannek H, Tuxhorn I (2002) Epilepsy surgery outcome in children with focal epilepsy due to tuberous sclerosis complex. Neuropediatrics 33:255–261
Romanelli P, Najjar S, Weiner HL, Devinsky O (2002) Epilepsy surgery in tuberous sclerosis: multistage procedures with bilateral or multilobar foci. J Child Neurol 17:689–692
Vigliano P, Canavese C, Bobba B, Genitori L, Papalia F, Padovan S, Forni M (2002) Transmantle dysplasia in tuberous sclerosis: clinical features and surgical outcome in four children. J Child Neurol 17:752–758
Kossoff EH, Vining EP, Pillas DJ, Pyzik PL, Avellino AM, Carson BS, Freeman JM (2003) Hemispherectomy for intractable unihemispheric epilepsy etiology vs outcome. Neurology 61:887–890
Mackay MT, Becker LE, Chuang SH, Otsubo H, Chuang NA, Rutka J, Ben-Zeev B, Snead OC 3rd, Weiss SK (2003) Malformations of cortical development with balloon cells: clinical and radiologic correlates. Neurology 60:580–587
Sinclair DB, Aronyk K, Snyder T, McKean J, Wheatley M, Bhargava R, Hoskinson M, Hao C, Colmers W (2003) Pediatric temporal lobectomy for epilepsy. Pediatr Neurosurg 38:195–205
Asano E, Juhasz C, Shah A, Muzik O, Chugani DC, Shah J, Sood S, Chugani HT (2005) Origin and propagation of epileptic spasms delineated on electrocorticography. Epilepsia 46:1086–1097
Sinclair DB, Wheatley M, Snyder T, Gross D, Ahmed N (2005) Posterior resection for childhood epilepsy. Pediatr Neurol 32:257–263
Lachhwani DK, Pestana E, Gupta A, Kotagal P, Bingaman W, Wyllie E (2005) Identification of candidates for epilepsy surgery in patients with tuberous sclerosis. Neurology 64:1651–1654
Weiner HL, Carlson C, Ridgway EB, Zaroff CM, Miles D, LaJoie J, Devinsky O (2006) Epilepsy surgery in young children with tuberous sclerosis: results of a novel approach. Pediatrics 117:1494–1502
Jansen FE, Van Huffelen AC, Van Rijen PC, Leijten FS, Jennekens-Schinkel A, Gosselaar P, Van Nieuwenhuizen O (2007) Epilepsy surgery in tuberous sclerosis: the Dutch experience. Seizure 16:445–453
Madhavan D, Schaffer S, Yankovsky A, Arzimanoglou A, Renaldo F, Zaroff CM, LaJoie J, Weiner HL, Andermann E, Franz DN, Leonard J, Connolly M, Cascino GD, Devinsky O (2007) Surgical outcome in tuberous sclerosis complex: a multicenter survey. Epilepsia 48:1625–1628
Teutonico F, Mai R, Devinsky O, Lo Russo G, Weiner HL, Borrelli P, Balottin U, Veggiotti P (2008) Epilepsy surgery in tuberous sclerosis complex: early predictive elements and outcome. Childs Nerv Syst 24:1437–1445
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moavero, R., Cerminara, C. & Curatolo, P. Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges. Childs Nerv Syst 26, 1495–1504 (2010). https://doi.org/10.1007/s00381-010-1128-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-010-1128-8